首页> 美国卫生研究院文献>Nucleic Acids Research >Cooperative genomic alteration network reveals molecular classification across 12 major cancer types
【2h】

Cooperative genomic alteration network reveals molecular classification across 12 major cancer types

机译:合作基因组改变网络揭示了12种主要癌症类型的分子分类

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The accumulation of somatic genomic alterations that enables cells to gradually acquire growth advantage contributes to tumor development. This has the important implication of the widespread existence of cooperative genomic alterations in the accumulation process. Here, we proposed a computational method HCOC that simultaneously consider genetic context and downstream functional effects on cancer hallmarks to uncover somatic cooperative events in human cancers. Applying our method to 12 TCGA cancer types, we totally identified 1199 cooperative events with high heterogeneity across human cancers, and then constructed a pan-cancer cooperative alteration network. These cooperative events are associated with genomic alterations of some high-confident cancer drivers, and can trigger the dysfunction of hallmark associated pathways in a co-defect way rather than single alterations. We found that these cooperative events can be used to produce a prognostic classification that can provide complementary information with tissue-of-origin. In a further case study of glioblastoma, using 23 cooperative events identified, we stratified patients into molecularly relevant subtypes with a prognostic significance independent of the Glioma-CpG Island Methylator Phenotype (GCIMP). In summary, our method can be effectively used to discover cancer-driving cooperative events that can be valuable clinical markers for patient stratification.
机译:使细胞逐渐获得生长优势的体细胞基因组改变的积累有助于肿瘤的发展。这具有重要的意义,即在积累过程中广泛存在合作基因组改变。在这里,我们提出了一种计算方法HCOC,该方法同时考虑了遗传背景和下游功能对癌症标志的影响,以揭示人类癌症中的体细胞合作事件。将我们的方法应用于12种TCGA癌症类型,我们共鉴定了1199个在人类癌症中具有高度异质性的合作事件,然后构建了一个泛癌合作伙伴变更网络。这些合作事件与某些高可信度癌症驱动程序的基因组改变有关,并且可能以共缺陷的方式而非单一改变触发标志性相关途径的功能障碍。我们发现这些合作事件可用于产生预后分类,该预后分类可提供与起源组织有关的补充信息。在进一步的胶质母细胞瘤案例研究中,我们使用确定的23种合作事件将患者分为具有预后意义的分子相关亚型,而这些预后独立于胶质瘤-CpG岛甲基化仪表型(GCIMP)。总而言之,我们的方法可以有效地用于发现驾驶癌症的合作事件,这些事件对于患者的分层可能是有价值的临床标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号